Spring Works Therapeutics (SWTX) PT Raised to $57 at JPMorgan, Following Announcement of New COM Patent For Nirogacestat
Tweet Send to a Friend
JPMorgan analyst Anupam Rama raised ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
